Keyphrases
South Africa
100%
South African
22%
AIDS/HIV
19%
HIV Vaccine
18%
HIV Prevention
18%
Vaccine Trial
17%
Vaccination
15%
Pretoria
14%
Placebo
12%
Pulmonary Tuberculosis
10%
Human Immunodeficiency Virus Type 1 (HIV-1)
10%
HIV-1 Infection
9%
Pregnant Women
9%
Neonatal Unit
9%
Men Who Have Sex with Men
9%
HIV Status
8%
Vaccine Effectiveness
8%
Unblinding
7%
Risk Behavior
7%
Healthcare Workers
7%
Gag-pol-nef
7%
HIV Infection
7%
Adverse Events
7%
Candidemia
7%
Multidrug-resistant Tuberculosis (MDR-TB)
7%
Residual Metabolic Activity
6%
HIV-1 Gag
6%
COVID-19
6%
Sexually Transmitted Infections
6%
Merck
6%
Adenovirus Type 5
6%
Fungemia
6%
S Vaccine
6%
Ad26
6%
Candida Auris
6%
Cryptococcal Meningitis
6%
Cross-sectional Observational Study
6%
Tertiary Hospital
6%
Acinetobacter Baumannii (A. baumannii)
6%
Randomized Placebo-controlled Trial
6%
Streptococcus Agalactiae
6%
Carbapenem-resistant Acinetobacter Baumannii
6%
Laboratory-based Surveillance
6%
CD4+ T
5%
Sexual Behavior
5%
Vaccine Response
5%
Developing Countries
5%
End of Treatment
5%
Aurès
5%
Whole Genome Sequencing
5%
Medicine and Dentistry
Human Immunodeficiency Virus
44%
Placebo
14%
Human Immunodeficiency Virus Vaccine
13%
Adverse Event
10%
Infection
10%
Prevalence
10%
Lung Tuberculosis
9%
Clinical Trial
7%
Human Immunodeficiency Virus 1 Infection
7%
High Risk Behavior
7%
Adolescence
7%
Positron Emission Tomography-Computed Tomography
7%
Serotype
7%
COVID-19
6%
Vaccine
6%
Fluorodeoxyglucose F 18
6%
Cryptococcal Meningitis
6%
Observational Study
6%
Chlamydia Trachomatis
6%
Men Who Have Sex with Men
6%
Disease
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%